102 related articles for article (PubMed ID: 14513403)
21. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.
Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J
Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882
[TBL] [Abstract][Full Text] [Related]
22. A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis.
Stein GE; Mummaw NL; Havlichek DH
Pharmacotherapy; 1995; 15(6):727-31. PubMed ID: 8602379
[TBL] [Abstract][Full Text] [Related]
23. [The Neisseria gonorhoeae and Chlamydia trachomatis coinfection in patients of Department of Dermatology and Venereology Medical University of Warsaw].
Młynarczyk-Bonikowska B; Skulska E; Walter de Walthoffen S; Młynarczyk G; Malejczyk M; Majewski S
Med Dosw Mikrobiol; 2015; 67(2):89-95. PubMed ID: 26591660
[TBL] [Abstract][Full Text] [Related]
24. In-vitro and in-vivo activity of roxithromycin against Chlamydia trachomatis.
Furneri PM; Sardo S; Cianci A; Palumbo G; Tempera G
J Chemother; 1991 Jan; 3 Suppl 1():36-8. PubMed ID: 12041782
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
Roblin PM; Hammerschlag MR
Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands.
van Rooijen MS; van der Loeff MF; Morré SA; van Dam AP; Speksnijder AG; de Vries HJ
Sex Transm Infect; 2015 May; 91(3):157-64. PubMed ID: 25237127
[TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Miyashita N; Matsumoto A; Matsushima T
Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the CT OligoGen kit with cobas 4800 assay for detection of Chlamydia trachomatis.
Parra-Sánchez M; Marcuello-López A; García-Rey S; Zakariya-Yousef I; Sivianes-Valdecantos N; Sierra-Atienza C; Bernal-Martínez S; Pueyo-Rodrígez I; Martín-Mazuelos E; Palomares-Folía JC
Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):642-5. PubMed ID: 25858681
[TBL] [Abstract][Full Text] [Related]
29. Comparison of different primer sets for detection of Chlamydia trachomatis by the polymerase chain reaction.
Roosendaal R; Walboomers JM; Veltman OR; Melgers I; Burger C; Bleker OP; MacClaren DM; Meijer CJ; van den Brule AJ
J Med Microbiol; 1993 Jun; 38(6):426-33. PubMed ID: 8510135
[TBL] [Abstract][Full Text] [Related]
30. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
31. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
[TBL] [Abstract][Full Text] [Related]
32. [New trends in research on group B streptococci (GBS) infections and sexual transmitted diseases].
Mikamo H
Jpn J Antibiot; 2004 Dec; 57(6):481-8. PubMed ID: 15747586
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of amplicor chlamydia PCR and LCX chlamydia LCR to detect Chlamydia trachomatis in synovial fluid.
Kuipers JG; Andresen J; Köhler L; Schnarr S; Putschky N; Zeidler H; Wollenhaupt J
Clin Exp Rheumatol; 2002; 20(2):185-92. PubMed ID: 12051397
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis.
Mikamo H; Ninomiya M; Tamaya T
Curr Ther Res Clin Exp; 2003 Jun; 64(6):375-7. PubMed ID: 24944386
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae among heterosexual men in Japan.
Wada K; Uehara S; Mitsuhata R; Kariyama R; Nose H; Sako S; Ishii A; Watanabe T; Matsumoto A; Monden K; Uno S; Araki T; Kumon H
J Infect Chemother; 2012 Oct; 18(5):729-33. PubMed ID: 22491994
[TBL] [Abstract][Full Text] [Related]
37. [Prevalence of cervical infection by Chlamydia trachomatis among Chilean women living in the Metropolitan Region].
Martínez T MA; Reid S I; Arias C; Napolitano R C; Sandoval Z J; Molina C R
Rev Med Chil; 2008 Oct; 136(10):1294-300. PubMed ID: 19194626
[TBL] [Abstract][Full Text] [Related]
38. Urine-based testing for Chlamydia trachomatis using polymerase chain reaction, leucocyte esterase and urethral and cervical smears.
Coble BI; Nordahl-Akesson E; Vinnerberg A; Kihlström E
Scand J Clin Lab Invest; 2006; 66(4):269-77. PubMed ID: 16777755
[TBL] [Abstract][Full Text] [Related]
39. Presence of Chlamydia trachomatis in young women in Northern Sardinia.
Zanetti S; Usai D; Molicotti P; Deriu A; Sechi LA
New Microbiol; 2007 Jan; 30(1):63-4. PubMed ID: 17319603
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
